tiprankstipranks
Trending News
More News >
Evofem Biosciences (EVFM)
OTHER OTC:EVFM
US Market

Evofem Biosciences (EVFM) Income Statement

Compare
1,211 Followers

Evofem Biosciences Income Statement

Last quarter (Q3 2025), Evofem Biosciences's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Evofem Biosciences's net income was $-1.68M. See Evofem Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 19.36M$ 18.22M$ 16.84M$ 8.24M$ 446.00K
Gross Profit
$ 15.53M$ 11.71M$ 12.42M$ 4.19M$ -1.20M
Operating Expenses
$ 23.20M$ 29.55M$ 96.55M$ 170.99M$ 102.42M
Depreciation and Amortization
$ 756.00K$ 1.78M$ 2.05M$ 1.02M$ 1.18M
EBITDA
$ -6.92M$ -16.07M$ -82.08M$ -165.78M$ -141.12M
Operating Income
$ -7.68M$ -17.85M$ -84.12M$ -166.80M$ -103.62M
Other Income/Expenses
$ -1.18M$ 70.84M$ 7.47M$ -38.37M$ -38.68M
Pretax Income
$ -8.86M$ 53.00M$ -76.65M$ -205.18M$ -142.31M
Net Income
$ -8.86M$ 52.98M$ -76.70M$ -205.19M$ -142.31M
Per Share Metrics
Basic EPS
$ -0.09$ 10.36$ -164.59$ -2.96K$ -3.97K
Diluted EPS
$ -0.09$ 0.05$ -164.59$ -2.96K$ -3.97K
Weighted Average Shares Outstanding
96.46M 4.83M 465.98K 69.82K 35.82K
Weighted Average Shares Outstanding (Diluted)
96.46M 984.04M 465.98K 69.82K 35.82K
Currency in USD

Evofem Biosciences Earnings and Revenue History